• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ECMO for ARDS due to COVID-19.

作者信息

Ñamendys-Silva Silvio A

机构信息

Department of Critical Care Medicine, Hospital Medica Sur, Instituto Nacional de Cancerologia & Intituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.

出版信息

Heart Lung. 2020 Jul-Aug;49(4):348-349. doi: 10.1016/j.hrtlng.2020.03.012. Epub 2020 Mar 26.

DOI:10.1016/j.hrtlng.2020.03.012
PMID:32223988
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194678/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e3/7194678/5d877f662f89/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e3/7194678/5d877f662f89/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e3/7194678/5d877f662f89/gr1_lrg.jpg

相似文献

1
ECMO for ARDS due to COVID-19.用于治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征的体外膜肺氧合
Heart Lung. 2020 Jul-Aug;49(4):348-349. doi: 10.1016/j.hrtlng.2020.03.012. Epub 2020 Mar 26.
2
Clinical feedback from experience with COVID-19: Specific considerations for extracorporeal membrane oxygenation.COVID-19临床经验反馈：体外膜肺氧合的特殊考量
J Infect. 2020 Sep;81(3):e59-e60. doi: 10.1016/j.jinf.2020.06.050. Epub 2020 Jun 21.
3
VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations.体外膜肺氧合（VV-ECMO）在新型冠状病毒肺炎（COVID-19）所致急性呼吸窘迫综合征（ARDS）中的应用：临床、实践及伦理考量
J Clin Anesth. 2020 Oct;65:109893. doi: 10.1016/j.jclinane.2020.109893. Epub 2020 May 20.
4
ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?用于治疗与新型冠状病毒肺炎相关的重症急性呼吸窘迫综合征的体外膜肺氧合：现在我们知道我们可以做到，但我们应该这么做吗？
Lancet Respir Med. 2020 Nov;8(11):1066-1068. doi: 10.1016/S2213-2600(20)30357-X. Epub 2020 Aug 13.
5
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).体外膜肺氧合（ECMO）在 2019 冠状病毒病（COVID-19）肺炎和急性呼吸窘迫综合征（ARDS）危重症患者中的应用。
Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364.
6
A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.1例体外膜肺氧合作为COVID-19相关严重急性呼吸窘迫综合征挽救治疗的病例：越来越多的证据
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620957778. doi: 10.1177/2324709620957778.
7
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?体外膜肺氧合（ECMO）：在治疗严重 COVID-19 中是否有作用？
Int J Infect Dis. 2020 May;94:78-80. doi: 10.1016/j.ijid.2020.03.058. Epub 2020 Apr 3.
8
Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far?2019冠状病毒病患者急性呼吸窘迫综合征的体外膜肺氧合：我们目前了解多少？
Perfusion. 2020 Sep;35(6):558-561. doi: 10.1177/0267659120934279. Epub 2020 Jun 24.
9
Extracorporeal membrane oxygenation and COVID-19: The causes of failure.体外膜肺氧合与新型冠状病毒肺炎：失败原因
J Card Surg. 2020 Oct;35(10):2838-2843. doi: 10.1111/jocs.14867. Epub 2020 Jul 17.
10
Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience.COVID-19 呼吸窘迫综合征的静脉-静脉体外膜肺氧合支持：初步经验。
ASAIO J. 2020 Jul;66(7):734-738. doi: 10.1097/MAT.0000000000001198.

引用本文的文献

1
Extracorporeal life support for adult patients with ARDS.成人急性呼吸窘迫综合征患者的体外生命支持
Intensive Care Med. 2025 Aug 6. doi: 10.1007/s00134-025-08070-1.
2
Clinical Profile and Course of Patients with Acute Respiratory Distress Syndrome due to COVID-19 in a Middle-Income Region in Mexico.墨西哥一个中等收入地区新冠肺炎所致急性呼吸窘迫综合征患者的临床特征与病程
J Crit Care Med (Targu Mures). 2024 Jul 31;10(3):245-253. doi: 10.2478/jccm-2024-0022. eCollection 2024 Jul.
3
Extracorporeal membrane oxygenation (ECMO) in patients with severe COVID-19 adult respiratory distress syndrome: a systematic review and meta-analysis.

本文引用的文献

1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
3
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
体外膜肺氧合（ECMO）用于重症新型冠状病毒肺炎成人呼吸窘迫综合征患者：一项系统评价与荟萃分析
Cardiothorac Surg. 2021;29(1):9. doi: 10.1186/s43057-021-00046-3. Epub 2021 Apr 12.
4
View Score: An early warning score to detect possible complications among COVID-19 patients.观察评分：一种用于检测新冠病毒疾病患者中可能出现并发症的早期预警评分。
J Family Med Prim Care. 2023 Dec;12(12):3160-3166. doi: 10.4103/jfmpc.jfmpc_221_23. Epub 2023 Dec 21.
5
Relationship between the Pre-ECMO and ECMO Time and Survival of Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.体外膜肺氧合（ECMO）治疗前时间和ECMO治疗时间与重症新型冠状病毒肺炎（COVID-19）患者生存的关系：一项系统评价和荟萃分析
J Clin Med. 2024 Feb 1;13(3):868. doi: 10.3390/jcm13030868.
6
Veno-venous extracorporeal membrane oxygenation for the treatment of respiratory compromise.静脉-静脉体外膜肺氧合用于治疗呼吸功能不全。
Indian J Thorac Cardiovasc Surg. 2023 Feb 8;39(Suppl 1):1-7. doi: 10.1007/s12055-022-01467-3.
7
Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review.用于治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征的体外膜肺氧合：一篇叙述性综述
J Intensive Care. 2023 Feb 8;11(1):5. doi: 10.1186/s40560-023-00654-7.
8
Circulating microRNAs as emerging regulators of COVID-19.循环 microRNAs 作为 COVID-19 的新兴调控因子。
Theranostics. 2023 Jan 1;13(1):125-147. doi: 10.7150/thno.78164. eCollection 2023.
9
Acute Respiratory Distress Syndrome and the Use of Inhaled Pulmonary Vasodilators in the COVID-19 Era: A Narrative Review.急性呼吸窘迫综合征与COVID-19时代吸入性肺血管扩张剂的应用：一篇叙述性综述
Life (Basel). 2022 Nov 2;12(11):1766. doi: 10.3390/life12111766.
10
Extracorporeal membrane oxygenation experience in COVID-19 pandemic: Report of two cases.新型冠状病毒肺炎大流行期间的体外膜肺氧合经验：两例报告。
North Clin Istanb. 2020 Nov 24;9(3):275-278. doi: 10.14744/nci.2020.86094. eCollection 2022.
中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
4
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus.体外膜肺氧合治疗重症中东呼吸综合征冠状病毒感染
Ann Intensive Care. 2018 Jan 10;8(1):3. doi: 10.1186/s13613-017-0350-x.
9
Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.医院体外膜肺氧合病例数量与死亡率的关联。体外生命支持组织登记处分析。
Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901. doi: 10.1164/rccm.201409-1634OC.